Contraception

New research presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that mandatory in-person consent and waiting periods in Ohio create significant delays and barriers to abortion access.

New expert guidelines emphasize trauma-informed care and nonpharmacological techniques to reduce pain and improve patient experience during intrauterine device insertion.

A new study reveals significantly increased abortion use among bisexual, lesbian, and mostly heterosexual individuals, underscoring gaps in reproductive health access.

New research links combined oral contraceptives to changes in the gut microbiome that may contribute to mood disorders.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Learn about the intersection of mental health and contraception, with evidence-based guidance on contraceptive options for patients with psychiatric conditions.

Two-thirds of US teen girls live in states with abortion bans, gestational limits, or parental involvement laws, limiting access to care.

While pain is a common deterrent for patients considering an IUD, there are no standardized guidelines for pain relief during insertion or removal.

A recent study presented at the ISSWSH 2025 Annual Meeting found no significant association between hormonal contraceptive use and the severity of clitoral adhesions, though researchers emphasize the need for further investigation.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Learn how clinicians can reduce pain during intrauterine device placement with evidence-based, patient-centered approaches to improve accessibility and patient experience.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent BMJ study reveals that hormonal contraceptives, particularly those containing oestrogen, may elevate the risk of ischemic stroke and heart attack, though absolute risks remain low.

A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reported an increase in US young adults seeking permanent contraception methods following the Supreme Court’s Dobbs v Jackson Women's Health Organization decision in 2022, highlighting the need for accessible contraception.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.

A new study finds that intrauterine instillation of 2% mepivacaine significantly lowers pain levels during intrauterine device placement.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

With nearly half of short-acting contraceptive users preferring non-traditional sources such as telehealth and over-the-counter options, a recent study highlights evolving patient needs in contraceptive access.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Following the Dobbs v. Jackson ruling, more women are opting for permanent and long-acting contraceptive methods, even in states where abortion access remains protected.

Find out what’s new and what this means for your practice.

In a recent study, similar bone health results were reported between oral contraceptive users with and without prune consumption, as well as nonusers.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.